Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Boone

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
Chemoprevention with theaflavins of rat esophageal intraepithelial neoplasia quantitatively monitored by image tile analysisC W Boone, G D Stoner, J V Bacus, et al.
Cancer Research|November 1, 1996
Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colonM Risio, M Lipkin, H Newmark, et al.
Cancer|May 15, 1982
Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cellsF C Austin, C W Boone, D L Levin, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Mechanistic considerations in chemopreventive drug developmentG J Kelloff, C W Boone, V E Steele, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1996
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventivesG J Kelloff, J R Fay, V E Steele, et al.
Hematology/Oncology Clinics of North America|January 15, 1999
Preclinical drug development paradigms for chemopreventivesV E Steele, C W Boone, R A Lubet, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Perspectives on chemoprevention agent selection and short-term clinical prevention trialsG J Kelloff, E T Hawk, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1997
Farnesyl protein transferase inhibitors as potential cancer chemopreventivesG J Kelloff, R A Lubet, J R Fay, et al.
Carcinogenesis|December 23, 1999
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassaysV E Steele, G J Kelloff, D Balentine, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000
Chemoprevention with theaflavins of rat esophageal intraepithelial neoplasia quantitatively monitored by image tile analysisC W Boone, G D Stoner, J V Bacus, et al.
Cancer Research|November 1, 1996
Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colonM Risio, M Lipkin, H Newmark, et al.
Cancer|May 15, 1982
Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cellsF C Austin, C W Boone, D L Levin, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Mechanistic considerations in chemopreventive drug developmentG J Kelloff, C W Boone, V E Steele, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1996
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventivesG J Kelloff, J R Fay, V E Steele, et al.
Hematology/Oncology Clinics of North America|January 15, 1999
Preclinical drug development paradigms for chemopreventivesV E Steele, C W Boone, R A Lubet, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Perspectives on chemoprevention agent selection and short-term clinical prevention trialsG J Kelloff, E T Hawk, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1997
Farnesyl protein transferase inhibitors as potential cancer chemopreventivesG J Kelloff, R A Lubet, J R Fay, et al.
Carcinogenesis|December 23, 1999
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassaysV E Steele, G J Kelloff, D Balentine, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.
Pageof 17